Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07020780 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

5 fr Ultrahypofractionated WBI and SIB for Breast Cancer With Unfavorable Characteristics

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Jul 1, 2025 to Jul 25, 2025 · Site details revisedv2 Show 2 more changesShow less
    • Start date changed from estimate of Jul 1, 2025 to Jul 25, 2025
    • Site details revised
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
IRCCS San Raffaele
234 trials monitored
See 1 trial at risk
Breast Cancer
5,213 trials monitored
See 271 trials at risk
This is a prospective, randomized, single-center, non-inferiority interventional clinical trial comparing whole breast irradiation (WBI) to a total dose of 26 Gy in 5 fractions with simultaneous integrated boost (SIB) to the tumor bed to a total dose of 30 Gy, and WBI to a total dose of 40.05 Gy in 15 fractions with SIB to the tumor bed to a total dose of 48 Gy (standard treatment), for young or unfavorable breast cancer patients.
Trial Details
NCT Number NCT07020780
Lead Sponsor IRCCS San Raffaele
Conditions Breast Cancer
Enrollment 458 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov